These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts. Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737 [TBL] [Abstract][Full Text] [Related]
6. mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Zimmermann A; Ritsch-Marte M; Kostron H Photochem Photobiol; 2001 Oct; 74(4):611-6. PubMed ID: 11683042 [TBL] [Abstract][Full Text] [Related]
7. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma. Ris HB; Giger A; Hof VI; Mettler D; Stewart JC; Althaus U; Altermatt HJ Eur J Cardiothorac Surg; 1997 Oct; 12(4):542-8. PubMed ID: 9370396 [TBL] [Abstract][Full Text] [Related]
8. Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts. Tran N; Krueger T; Pan Y; Yan H; Cheng C; Altermatt HJ; Ballini JP; Borle F; Ris HB; Andrejevic-Blant S Lasers Surg Med; 2007 Mar; 39(3):237-44. PubMed ID: 17345623 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index. Ris HB; Altermatt HJ; Stewart CM; Schaffner T; Wang Q; Lim CK; Bonnett R; Althaus U Int J Cancer; 1993 Sep; 55(2):245-9. PubMed ID: 8370622 [TBL] [Abstract][Full Text] [Related]
10. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy. Braichotte DR; Savary JF; Monnier P; van den Bergh HE Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430 [TBL] [Abstract][Full Text] [Related]
11. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results. Schouwink H; Rutgers ET; van der Sijp J; Oppelaar H; van Zandwijk N; van Veen R; Burgers S; Stewart FA; Zoetmulder F; Baas P Chest; 2001 Oct; 120(4):1167-74. PubMed ID: 11591556 [TBL] [Abstract][Full Text] [Related]
12. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792 [TBL] [Abstract][Full Text] [Related]
13. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma. Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733 [TBL] [Abstract][Full Text] [Related]
14. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244 [TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
16. Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology. Ris HB; Li Q; Krueger T; Lim CK; Reynolds B; Althaus U; Altermatt HJ Int J Cancer; 1998 Jun; 76(6):872-4. PubMed ID: 9626355 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols. Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma. Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108 [TBL] [Abstract][Full Text] [Related]
19. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review. Horlings RK; Terra JB; Witjes MJ Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic action of meta-tetrahydroxyphenylchlorin (mTHPC) on an ovarian cancer cell line. Gharehbaghi K; Kubin A; Grusch M; Gharehbaghi-Schnell E; Wierrani F; Jayaram HN; Grunberger W; Szekeres T Anticancer Res; 2000; 20(4):2647-52. PubMed ID: 10953338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]